Pharma Pulse 2/18/25: HCP and Patient Influence on the CGT Approval Process, Enhancing Care for ALZ Patients & more

How HCPs and Patients Influence the CGT Approval Process

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, describes why these pharma supply chain stakeholders are vital in understanding meaningful clinical outcomes.

Pharmacists at the Forefront: Enhancing Care for Patients With Alzheimer Disease Receiving Disease Modifying-Treatment

Pharmacists can support patients with treatment education, monitoring, and adherence, helping to overcome challenges posed by cognitive decline.

Irish Exports Hit Record in 2024 on Medical, Pharma Goods

Irish exports hit a record level in 2024, according to new data, largely driven by a boost in medical and pharmaceutical products being sent abroad.

New ‘Super Test’ for Prostate Cancer Developed in the UK by EDX Medical

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionize screening and diagnosis of the disease and accelerate personalized treatment for patients.

The test identifies the presence or absence of cancerous cells, signs of early and late-stage cancer, whether it is slow or aggressive as well as genetic and hereditary risks in the patient. It also involves studying the most comprehensive combination of clinically-validated prostate-related biomarkers currently known, in both blood and urine samples. The interpretation of these biomarkers using a proprietary AI-driven algorithm highlights early signs of cancer and characteristic features that can guide treatment selection.

Mike Christel on LinkedIn

Click below to read my cover story on Teva Pharmaceuticals CEO Richard Francis for the February issue of Pharmaceutical Executive. Drawing from a candid and wide-ranging conversation with the CEO, I chronicle Teva’s path back to growth under his leadership—and the bold shifts in vision, strategy, and mindset that have shaped the company's post-"survival" resurgence.

❝You don’t turn a big organization like this around without everybody deciding they want to do it and everybody moving in one direction.❞

Go inside the journey. Hope you enjoy.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs